Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial.

Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial.

Killed oral cholera vaccines (OCVs) have been licensed for use in developing countries, but protection conferred by licensed OCVs beyond two years of follow-up has not been demonstrated in randomized, clinical trials.We conducted a cluster-randomized, placebo-controlled trial of a two-dose regimen o...

Full description

Bibliographic Details
Main Authors: Dipika Sur, Suman Kanungo, Binod Sah, Byomkesh Manna, Mohammad Ali, Allison M Paisley, Swapan K Niyogi, Jin Kyung Park, Banawarilal Sarkar, Mahesh K Puri, Deok Ryun Kim, Jacqueline L Deen, Jan Holmgren, Rodney Carbis, Raman Rao, Thu Van Nguyen, Seung Hyun Han, Stephen Attridge, Allan Donner, Nirmal K Ganguly, Sujit K Bhattacharya, G Balakrish Nair, John D Clemens, Anna Lena Lopez
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-10-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC3196468?pdf=render

Internet

http://europepmc.org/articles/PMC3196468?pdf=render

Similar Items